Table S1.
Patient and normal tissue information and the percentage of HTRA3-positive staining area
| Catalog number | Position | Sex | Age (years) | Organ | Pathology | Grade | Stage | TNM | Type | HTRA3-positive staining area (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| PA483c | A5 | F | 67 | Pancreas | Duct adenocarcinoma | 1 | IIB | T3N1BM0 | Malignant | 0.3 |
| PA483c | A7 | F | 56 | Pancreas | Duct adenocarcinoma | 1 | IB | T2N0M0 | Malignant | 1 |
| PA483c | A8 | M | 74 | Pancreas | Duct adenocarcinoma | 1 | IIA | T3N0M0 | Malignant | 4.4 |
| PA483c | B1 | F | 72 | Pancreas | Duct adenocarcinoma | 2 | IIA | T3N0M0 | Malignant | 9 |
| PA483c | B2 | M | 49 | Pancreas | Duct adenocarcinoma | 1 | IIB | T3N1M0 | Malignant | 3.1 |
| PA483c | B5 | F | 48 | Pancreas | Duct adenocarcinoma | 1 | IIA | T3N0M0 | Malignant | 7.9 |
| PA483c | B6 | F | 76 | Pancreas | Duct adenocarcinoma | 2 | IIA | T3N0M0 | Malignant | 4.2 |
| PA483c | B7 | M | 57 | Pancreas | Duct adenocarcinoma | 2 | IIA | T3N0M0 | Malignant | 4.7 |
| PA483c | C1 | M | 47 | Pancreas | Duct adenocarcinoma | 2 | IIA | T3N0M0 | Malignant | 6.9 |
| PA483c | C2 | M | 31 | Pancreas | Duct adenocarcinoma | 2 | IIA | T3N0M0 | Malignant | 5.7 |
| PA483c | C3 | M | 64 | Pancreas | Duct adenocarcinoma | 3 | IIA | T3N0M0 | Malignant | 4.1 |
| PA483c | C4 | M | 44 | Pancreas | Duct adenocarcinoma | 2 | II | T3N0M0 | Malignant | 5.6 |
| PA483c | C5 | M | 57 | Pancreas | Duct adenocarcinoma | 2 | IIA | T3N0M0 | Malignant | 3.7 |
| PA483c | C6 | M | 61 | Pancreas | Duct adenocarcinoma | 2 | IB | T2N0M0 | Malignant | 6.5 |
| PA483c | C7 | M | 65 | Pancreas | Duct adenocarcinoma | 2 | IIA | T3N0M0 | Malignant | 4.2 |
| PA483c | C8 | M | 52 | Pancreas | Duct adenocarcinoma (sparse) | 2 | IA | T1N0M0 | Malignant | 0.5 |
| PA483c | D1 | M | 49 | Pancreas | Duct adenocarcinoma | 2 | IIA | T3N0M0 | Malignant | 4.5 |
| PA483c | D2 | F | 47 | Pancreas | Duct adenocarcinoma | 3 | IIB | T3N1M0 | Malignant | 8.1 |
| PA483c | D3 | M | 45 | Pancreas | Duct adenocarcinoma | 2 | IIA | T3N0M0 | Malignant | 1.9 |
| PA483c | D5 | M | 52 | Pancreas | Adenocarcinoma | 3 | IB | T2N0M0 | Malignant | 8.7 |
| PA483c | D6 | F | 62 | Pancreas | Adenocarcinoma | 3 | II | T3N0M0 | Malignant | 2.9 |
| PA483c | D7 | F | 51 | Pancreas | Adenocarcinoma | 3 | IIA | T3N0M0 | Malignant | 13.5 |
| PA483c | D8 | F | 48 | Pancreas | Adenocarcinoma | 3 | IIA | T3N0M0 | Malignant | 1.9 |
| PA483c | E1 | M | 61 | Pancreas | Adenocarcinoma | 3 | IV | T3N0M1 | Malignant | 6.3 |
| PA483c | E2 | M | 78 | Pancreas | Adenocarcinoma | 3 | IIA | T3N0M0 | Malignant | 9.1 |
| PA483c | E3 | M | 52 | Pancreas | Duct adenocarcinoma | 2 | IA | T2N0M0 | Malignant | 8.5 |
| PA483c | E4 | M | 56 | Pancreas | Adenocarcinoma | 3 | IA | T2N0M0 | Malignant | 20.3 |
| PA483c | E5 | F | 51 | Pancreas | Adenocarcinoma | 3 | IIA | T3N0M0 | Malignant | 13.6 |
| PA483c | E6 | F | 56 | Pancreas | Adenocarcinoma | 3 | IIA | T3N0M0 | Malignant | 17 |
| PA483c | E7 | F | 66 | Pancreas | Acinic cell carcinoma | NA | IB | T2N0M0 | Malignant | 7.6 |
| PA483c | E8 | M | 62 | Pancreas | Squamous cell carcinoma | 2 | IIA | T3N0M0 | Malignant | 11.7 |
| PA483c | F1 | F | 35 | Pancreas | Pancreatic tissue | NA | NA | NA | Normal | 22.7 |
| PA483c | F2 | M | 40 | Pancreas | Pancreatic tissue | NA | NA | NA | Normal | 7.6 |
| PA483c | F3 | F | 21 | Pancreas | Pancreatic tissue | NA | NA | NA | Normal | 16.9 |
| PA483c | F4 | M | 35 | Pancreas | Pancreatic tissue | NA | NA | NA | Normal | 19.1 |
| PA483c | F5 | M | 47 | Pancreas | Pancreatic tissue | NA | NA | NA | Normal | 7.3 |
| PA483c | F6 | F | 21 | Pancreas | Pancreatic tissue | NA | NA | NA | Normal | 18.8 |
| PA483c | F7 | M | 30 | Pancreas | Pancreatic tissue | NA | NA | NA | Normal | 3.3 |
| PA483c | F8 | M | 30 | Pancreas | Pancreatic tissue | NA | NA | NA | Normal | 8.1 |
Abbreviations: F, female; M, male; NA, not available.